Jeremiah Gerdin serves as Vice President of U.S. Commercial at Biocartis. He joined the company in 2024 and is responsible for U.S. sales, commercial operations, customer service, customer support, and sales enablement. Mr. Gerdin brings 15 years of experience in molecular and oncology diagnostics, with a proven track record of building high-performing teams and executing go-to-market strategies that drive sustained growth. Prior to Biocartis, he held multiple leadership roles at NeoGenomics, advancing from sales representative to Head of Commercial Operations. In that capacity, he led national sales strategies, implemented operational best practices, and helped scale the organization through a period of rapid growth. Earlier in his career, he held clinical sales roles at Hologic, focused on women's health diagnostics. Mr. Gerdin holds a Bachelor’s degree in Biochemistry and an MBA from the Carlson School of Management with a specialization in Finance and Healthcare.